• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biochem Biophys Res Commun. Structure analysis of the receptor binding of 2019-nCoV

tetano

Editor, Senior Moderator
Biochem Biophys Res Commun. 2020 Feb 17. pii: S0006-291X(20)30339-9. doi: 10.1016/j.bbrc.2020.02.071. [Epub ahead of print] [h=1]Structure analysis of the receptor binding of 2019-nCoV.[/h]
Chen Y[SUP]1[/SUP], Guo Y[SUP]1[/SUP], Pan Y[SUP]2[/SUP], Zhao ZJ[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] 2019-nCoV is a newly identified coronavirus with high similarity to SARS-CoV. We performed a structural analysis of the receptor binding domain (RBD) of spike glycoprotein responsible for entry of coronaviruses into host cells. The RBDs from the two viruses share 72% identity in amino acid sequences, and molecular simulation reveals highly similar ternary structures. However, 2019-nCoV has a distinct loop with flexible glycyl residues replacing rigid prolyl residues in SARS-CoV. Molecular modeling revealed that 2019-nCoV RBD has a stronger interaction with angiotensin converting enzyme 2 (ACE2). A unique phenylalanine F486 in the flexible loop likely plays a major role because its penetration into a deep hydrophobic pocket in ACE2. ACE2 is widely expressed with conserved primary structures throughout the animal kingdom from fish, amphibians, reptiles, birds, to mammals. Structural analysis suggests that ACE2 from these animals can potentially bind RBD of 2019-nCoV, making them all possible natural hosts for the virus. 2019-nCoV is thought to be transmitted through respiratory droplets. However, since ACE2 is predominantly expressed in intestines, testis, and kidney, fecal-oral and other routes of transmission are also possible. Finally, antibodies and small molecular inhibitors that can block the interaction of ACE2 with RBD should be developed to combat the virus.
Copyright ? 2020 The Authors. Published by Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Coronavirus; Molecular modeling; Sequence analysis; Structure analysis

PMID: 32081428 DOI: 10.1016/j.bbrc.2020.02.071
Free full text
 
Back
Top